{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:25:57Z","timestamp":1790868357769,"version":"4.1.0"},"reference-count":42,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Many new clinical trials about the effect of omega-3 polyunsaturated fatty acids (PUFAs) in heart failure (HF) patients have shown inconsistent results. Therefore, a meta-analysis of randomised controlled trials (RCTs) was performed to determine the benefits of omega-3 PUFAs in HF patients. Articles were obtained from PubMed, EMBASE, and the Cochrane Library. RCTs comparing omega-3 PUFAs with placebo for HF were included. Two reviewers independently extracted the data from the selected publications. The I2 statistic was used to assess heterogeneity. The pooled mean difference and associated 95% confidence intervals were calculated, and a fixed or random-effects model was used for the meta-analysis. A total of nine RCTs involving 800 patients were eligible for inclusion. Compared with patients taking placebo, HF patients who received omega-3 PUFAs experienced decreased brain natriuretic peptide levels and serum norepinephrine levels. Although the left ventricular ejection fraction (LVEF) and clinical outcomes (Tei index, peak oxygen consumption) did not improve, subgroup analysis showed that the LVEF increased in dilated cardiomyopathy (DCM) patients. Overall, omega-3 PUFA supplements might be beneficial in HF patients, especially in DCM patients, but further studies are needed to confirm these benefits.<\/jats:p>","DOI":"10.3390\/nu9010018","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T08:48:53Z","timestamp":1483087733000},"page":"18","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Role of Omega-3 Polyunsaturated Fatty Acids in Heart Failure: A Meta-Analysis of Randomised Controlled Trials"],"prefix":"10.3390","volume":"9","author":[{"given":"Chunbin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ehf2.12005","article-title":"Heart Failure. Preventing Disease and Death Worldwide","volume":"1","author":"Piotr","year":"2014","journal-title":"ESC Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics\u20142011 update: A report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: A population study of 5.1 million people","volume":"119","author":"Jhund","year":"2009","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","article-title":"Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids","volume":"68","author":"Wall","year":"2010","journal-title":"Nutr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.jacc.2005.03.038","article-title":"Fish intake and risk of incident heart failure","volume":"45","author":"Mozaffarian","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ejheart.2005.04.008","article-title":"Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids","volume":"7","author":"Macchia","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2008.06.018","article-title":"Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) study","volume":"52","author":"Yamagishi","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ahj.2008.06.017","article-title":"Plasma fatty acid composition and incident heart failure in middle-aged adults: The atherosclerosis risk in Communities (ARIC) Study","volume":"156","author":"Yamagishi","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"ref_10","first-page":"1620","article-title":"Effects of fish oil supplementation on cardiac function in chronic heart failure: A meta-analysis of randomised controlled trials","volume":"98","author":"Xin","year":"2012","journal-title":"Heart (Br. Card. Soc.)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcdr.2013.02.013","article-title":"Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure: Double-blind placebo-controlled randomized trial","volume":"4","author":"Kojuri","year":"2013","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.5551\/jat.21022","article-title":"Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia","volume":"21","author":"Kohashi","year":"2014","journal-title":"J. Atheroscleros. Thromb."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/2047487314536694","article-title":"No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: The alpha omega trial","volume":"22","author":"Hoogeveen","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vph.2016.01.005","article-title":"Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; a randomized clinical trial","volume":"79","author":"Chrysohoou","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurjhf\/hfq172","article-title":"Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: A substudy of GISSI-HF trial","volume":"12","author":"Ghio","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jacc.2010.11.017","article-title":"Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy","volume":"57","author":"Nodari","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"915.e1","DOI":"10.1016\/j.ahj.2011.02.011","article-title":"Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: A double-blind, placebo-controlled, 3-arm study","volume":"161","author":"Moertl","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1177\/147323000903700619","article-title":"Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure","volume":"37","author":"Zhao","year":"2009","journal-title":"J. Int. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10557-008-6142-7","article-title":"The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy","volume":"23","author":"Nodari","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2006.05.073","article-title":"Enhanced baroreceptor control of the cardiovascular system by polyunsaturated Fatty acids in heart failure patients","volume":"48","author":"Radaelli","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.healun.2006.03.005","article-title":"Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure","volume":"25","author":"Mehra","year":"2006","journal-title":"J. Heart Lung Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","article-title":"Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure","volume":"38","author":"Koglin","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0735-1097(01)01383-3","article-title":"Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction","volume":"38","author":"Stanek","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/01.CIR.0000016642.15031.34","article-title":"B-type natriuretic peptide predicts sudden death in patients with chronic heart failure","volume":"105","author":"Berger","year":"2002","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2003.11.059","article-title":"B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure","volume":"43","author":"Dagorn","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehp420","article-title":"N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population","volume":"31","author":"Linssen","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2008.02.014","article-title":"Body mass index and mortality in heart failure: A meta-analysis","volume":"156","author":"Oreopoulos","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2016.03.007","article-title":"Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias","volume":"82","author":"Gluck","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.3390\/nu6104058","article-title":"The role for dietary omega-3 fatty acids supplementation in older adults","volume":"6","author":"Molfino","year":"2014","journal-title":"Nutrients"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.18632\/aging.101077","article-title":"Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction","volume":"8","author":"Halade","year":"2016","journal-title":"Aging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00395-014-0444-7","article-title":"Inflammation revisited: Inflammation versus resolution of inflammation following myocardial infarction","volume":"109","author":"Kain","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ejhf.19","article-title":"The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: Insights from the ASCEND-HF Trial","volume":"16","author":"Toma","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacc.2010.11.014","article-title":"Polyunsaturated fatty acids in heart failure: Should we give more and give earlier?","volume":"57","author":"Tang","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cvr\/cvp169","article-title":"Omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: Mechanisms and clinical potential","volume":"84","author":"Duda","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_37","first-page":"110","article-title":"n-3 polyunsaturated fatty acids in heart failure: Mechanisms and recent clinical evidence","volume":"56","author":"Marchioli","year":"2010","journal-title":"Cell. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/jn\/137.11.2377","article-title":"(n-3) Long Chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats","volume":"137","author":"Pepe","year":"2007","journal-title":"J. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/eurheartj\/ehs041","article-title":"The human sympathetic nervous system: Its relevance in hypertension and heart failure","volume":"33","author":"Parati","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.02.005","article-title":"The autonomic nervous system and cardiovascular disease: Role of n-3 PUFAs","volume":"71","author":"Christensen","year":"2015","journal-title":"Vasc. Pharmacol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/1\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:29:33Z","timestamp":1760210973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/1\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["nu9010018"],"URL":"https:\/\/doi.org\/10.3390\/nu9010018","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}